HSBC Holdings’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$64.3K Sell
2024
Q4
$75.6K Hold
2024
Q3
$41.2K Sell
2024
Q2
$58.1K Buy
2024
Q1
$58.8K Buy
2023
Q4
$70.9K Hold
2023
Q3
$64.5K Buy
2016
Q2
Sell
2016
Q1
$13K Buy
2014
Q2
Sell
2014
Q1
$129K Buy